Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
Secondary osteoporosis may occur in patients with rheumatoid arthritis (RA), causing irreversible joint damage and disability. Bisphosphonates, the recently developed bone resorption inhibitors, have demonstra...
Source: Journal of Orthopaedic Surgery and Research - Category: Orthopaedics Authors: Jun Xie, Shaohua Li, Lianbo Xiao, Guilin Ouyang, Lin Zheng, Yubiao Gu, Chengxin Gao and Xiuwei Han Tags: Research article Source Type: research
More News: Arthritis | Disability | Orthopaedics | Osteoporosis | Reclast | Rheumatoid Arthritis | Rheumatology | Zometa